HBM Healthcare Investments
Research HBM Healthcare Investments (HBMN) on Bullrun: valuation model: 42.8% undervalued, market cap CHF 1.54B, P/E 5.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHBMN
- ExchangeSW
- CountrySwitzerland
- SectorFinancial Services
- IndustryAsset Management
- CurrencyCHF
- Valuation signal42.8% undervalued
- Market capCHF 1.54B
- P/E5.7
- Financial periodQ1 2026
- Revenue-CHF 13.90M
- Net income-CHF 14.57M
- Free cash flow-CHF 348.00K
Valuation Snapshot
Bullrun's latest valuation model marks HBM Healthcare Investments as 42.8% undervalued; latest market cap is CHF 1.54B; P/E is 5.7.
About HBM Healthcare Investments
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds.
Frequently asked questions
Is HBM Healthcare Investments overvalued or undervalued?
Bullrun's valuation model currently marks HBM Healthcare Investments as 42.8% undervalued.
What is HBM Healthcare Investments's market cap?
HBM Healthcare Investments's market capitalization is CHF 1.54B.
What is HBM Healthcare Investments's P/E ratio?
HBM Healthcare Investments's price-to-earnings (P/E) ratio is 5.7.
What does HBM Healthcare Investments do?
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public...